Nuclear factor kappa B in the dorsal raphe of macaques: An anatomical link for steroids, cytokines and serotonin

Journal of Psychiatry and Neuroscience

Volumn 31, Issue 2, 2006, Pages 105-114

  Bethea, Cynthia L ^a   Reddy, Arubala P ^a   Smith, Lisa J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Blotting; Estrogen; Immunohistochemistry; NF kappa B; Progesterone; Reverse transcriptase polymerase chain reaction; Serotonin; Western

Indexed keywords

CYTOKINE; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLACEBO; PROGESTERONE; SEROTONIN; STEROID;

ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FEMALE; IMMUNOHISTOCHEMISTRY; MACACA; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEREOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; DATA INTERPRETATION, STATISTICAL; DNA PRIMERS; FEMALE; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; NEURONS; NF-KAPPA B; RAPHE NUCLEI; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEROTONIN; STEROIDS;

EID: 33645893490     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Menon SD, Guy GR, Tan YH. Involvement of a putative protein-tyrosine phosphatase and I kappa B-alpha serine phosphorylation in nuclear factor kappa B activation by tumor necrosis factor. J Biol Chem 1995;270:18881-7.
2. Anisman H, Ravindran AV, Griffiths J, et al. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 1999;4:182-8.
3. Pollak Y, Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 2002;5:389-99.
4. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev 1992;72:165-231.
5. Arango V, Underwood MD, Mann JJ. Serotonin brain circuits involved in major depression and suicide. Prog Brain Res 2002;136: 443-53.
6. Bethea CL, Lu NZ, Gundlah C, et al. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 2002; 23:41-100.
7. Kuiper GGJM, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997;138:863-70.
8. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994;63:451-86.
9. Gundlah C, Kohama SG, Mirkes SJ, et al. Distribution of estrogen receptor beta (ERβ) mRNA in hypothalamus, midbrain and temporal lobe of spayed macaque: continued expression with hormone replacement. Brain Res Mol Brain Res 2000;76:191-204.
10. Gundlah C, Lu NZ, Mirkes SJ, et al. Estrogen receptor beta (ERβ) mRNA and protein in serotonin neurons of macaques. Brain Res Mol Brain Res 2001;91:14-22.
11. Bethea CL. Regulation of progestin receptors in raphe neurons of steroid-treated monkeys. Neuroendocrinology 1994;60:50-61.
12. Sanchez RL, Reddy AP, Centeno ML, et al. A second tryptophan hydroxylase isoform, TPH-2 mRNA, is increased by ovarian steroids in the raphe region of macaques. Brain Res Mol Brain Res 2005;135:194-203.
13. Pecins-Thompson M, Brown NA, Bethea CL. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res 1998;53:120-9.
14. Pecins-Thompson M, Bethea CL. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 1999;89:267-77.
15. Gundlah C, Lu NZ, Bethea CL. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 2002;160: 271-82.
16. Heils A, Teufel A, Petri S, et al. Functional promoter and polyadenylation site mapping of the human serotonin (5HT) transporter gene. J Neural Transm Gen Sect 1995;102:247-54.
17. Shih JC, Zhu QS, Chen K. Expression of human monoamine oxidase (MAO). A gene controlled by transcription faction Sp1. Prog Brain Res 1995;106:49-56.
18. Parks CL, Shenk T. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J Biol Chem 1996;271:4417-30.
19. Wissink S, Meijer O, Pearce D, et al. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J Biol Chem 2000;275: 1321-6.
20. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactions between nuclear factor kappa B and steroid receptor-signaling pathways. Endocr Rev 1999;20:435-59.
21. Cerillo G, Rees A, Manchanda N, et al. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner. J Steroid Biochem Mol Biol 1998;67:79-88.
22. Deshpande R, Khalili H, Pergolizzi RG, et al. Estradiol downregulates LPS-induced cytokine production and NF-κB activation in murine macrophages. Am J Reprod Immunol 1997;38:46-54.
23. Smith LJ, Henderson JA, Abell CW, et al. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 2004;29:2035-45.
24. Bethea CL, Streicher JM, Mirkes SJ, et al. Serotonin-related gene expression in female monkeys with individual sensitivity to stress. Neuroscience 2005;132:151-66.
25. Lu NZ, Bethea CL. Ovarian steroid regulation of 5HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 2002;27:12-24.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
27. Reddy AP, Bethea CL. Preliminary array analysis reveals novel genes regulated by ovarian steroids in the monkey raphe region. Psychopharmacology (Berl) 2005;180:125-40.
28. Bethea CL, Lu NZ, Reddy A, et al. Characterization of reproductive steroid receptors and response to estrogen in a rat serotonergic cell line. J Neurosci Methods 2003;127:31-41.
29. Barnes PJ. Nuclear factor-kappa B. Int J Biochem Cell Biol 1997;29: 867-70.
30. Wu CY, Hsieh HL, Jou MJ, et al. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J Neurochem 2004;90:1477-88.
31. Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 2002;5:375-88.
32. Tuglu C, Kara SH, Caliyurt O, et al. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003;170:429-33.
33. Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 2003;61:519-25.
34. Wissink S, van Heerde EC, van der Burg B, et al. A dual mechanism mediates repression of NF-kB activity by glucocorticoids. Mol Endocrinol 1998;12:355-63.
35. Kanematsu M, Sato T, Takai H, et al. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J Bone Miner Res 2000;15: 1321-9.
36. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-κB and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 1998;12:45-56.
37. Van der Burg B, van der Saag PT. Nuclear factor-kappa-/steroid hormone receptor interactions as a functional basis of anti-inflammatory action of steroids in reproductive organs. Mol Hum Reprod 1996;2:433-8.
38. Wen Y, Yang S, Liu R, et al. Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res 2004;1008:147-54.
39. McKay LI, Cidlowski JA. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor -kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 2000;14:1222-34.
40. Lee JI, Burckart GJ. Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol 1998;38:981-93.
41. Han HS, Karabiyikoglu M, Kelly S, et al. Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J Cereb Blood Flow Metab 2003;23:589-98.
42. Aggarwal BB. Apoptosis and nuclear factor-kappa B: a tale of association and dissociation. Biochem Pharmacol 2000;60:1033-9.
43. Bhakar AL, Tannis LL, Zeindler C, et al. Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci 2002;22:8466-75.
44. Cechetto DF. Role of nuclear factor kappa B in neuropathological mechanisms. Prog Brain Res 2001;132:391-404.
45. Katzenellenbogen BS, Katzenellenbogen JA. Defining the "S" in SERMs. Science 2002;295:2380-1.
46. Buelke-Sam J, Bryant HU, Francis PC. The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing. Reprod Toxicol 1998;12:217-21.
47. Strickler R, Stovall DW, Merritt D, et al. Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial. Obstet Gynecol 2000;96:359-65.
48. Neele SJ, Rombouts SA, Bierlaagh MA, et al. Raloxifene affects brain activation patterns in postmenopausal women during visual encoding. J Clin Endocrinol Metab 2001;86:1422-4.
49. Florio P, Quirici B, Casarosa E, et al. Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women. Gynecol Endocrinol 2001;15:359-66.